Vir Biotechnology, Inc.·4

Feb 18, 5:01 PM ET

Rice Steven J. 4

4 · Vir Biotechnology, Inc. · Filed Feb 18, 2021

Insider Transaction Report

Form 4
Period: 2021-02-16
Rice Steven J.
Chief Administrative Officer
Transactions
  • Award

    Common Stock

    2021-02-16+20,00020,000 total
  • Award

    Stock Option (Right to Buy)

    2021-02-16+40,00040,000 total
    Exercise: $67.38Exp: 2031-02-15Common Stock (40,000 underlying)
Footnotes (2)
  • [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
  • [F2]1/4 of the shares subject to the stock option vest and become exercisable on February 16, 2022, and the remainder vest in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION